We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.83B
AUM Growth
+$365M
Cap. Flow
+$14.3M
Cap. Flow %
0.37%
Top 10 Hldgs %
46.82%
Holding
177
New
6
Increased
30
Reduced
82
Closed
1

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$20M
2
LH icon
Labcorp
LH
+$18.1M
3
SCHW
Charles Schwab
SCHW
+$10.1M
4
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$9.96M
5
WAT icon
Waters Corp
WAT
+$3.78M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$15.9M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
WMS icon
Advanced Drainage Systems
WMS
+$7.62M
4
MA icon
Mastercard
MA
+$3.36M
5
MDXG icon
MiMedx Group
MDXG
+$3.01M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Technology 13.69%
3 Healthcare 13.2%
4 Communication Services 7.56%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKI
101
DELISTED
Black Knight, Inc. Common Stock
BKI
$927K 0.02%
15,525
-11,600
-43% -$651K
FTRE icon
102
Fortrea Holdings
FTRE
$1.93B
$901K 0.02%
+26,500
New +$882K
SHEL icon
103
Shell
SHEL
$244B
$891K 0.02%
14,757
-1,000
-6% -$60K
IDXX icon
104
Idexx Laboratories
IDXX
$44.9B
$879K 0.02%
1,750
-100
-5% -$47.9K
ADP icon
105
Automatic Data Processing
ADP
$109B
$845K 0.02%
3,845
-126
-3% -$27.2K
FAST icon
106
Fastenal
FAST
$54.8B
$826K 0.02%
28,000
– –
JPM.PRC icon
107
JPMorgan Chase & Co 6.00% Series EE Preferred Stock
JPM.PRC
$1.86B
$799K 0.02%
31,412
– –
MCD icon
108
McDonald's
MCD
$193B
$746K 0.02%
2,500
– –
CBSH icon
109
Commerce Bancshares
CBSH
$8.68B
$724K 0.02%
17,205
– –
BNY
110
Bank of New York Mellon
BNY
$103B
$713K 0.02%
16,013
– –
TMO icon
111
Thermo Fisher Scientific
TMO
$214B
$700K 0.02%
1,341
– –
COP icon
112
ConocoPhillips
COP
$144B
$618K 0.02%
5,961
-149
-2% -$15.3K
BB icon
113
BlackBerry
BB
$4.58B
$615K 0.02%
111,250
-700
-0.6% -$3.39K
TSLA icon
114
Tesla
TSLA
$1.18T
$593K 0.02%
2,265
-60
-3% -$12K
TSCO icon
115
Tractor Supply
TSCO
$16.3B
$589K 0.02%
13,325
-3,300
-20% -$151K
CHCO icon
116
City Holding Co
CHCO
$2.05B
$561K 0.01%
6,239
-220
-3% -$20K
KMI icon
117
Kinder Morgan
KMI
$70.9B
$499K 0.01%
28,975
-2,975
-9% -$50.5K
IEX icon
118
IDEX
IEX
$17B
$484K 0.01%
2,250
– –
UNH icon
119
UnitedHealth
UNH
$382B
$483K 0.01%
1,004
– –
GIS icon
120
General Mills
GIS
$20.2B
$460K 0.01%
6,000
– –
CARR icon
121
Carrier Global
CARR
$49.8B
$449K 0.01%
9,024
– –
PAYX icon
122
Paychex
PAYX
$43.4B
$447K 0.01%
4,000
– –
BMY icon
123
Bristol-Myers Squibb
BMY
$129B
$445K 0.01%
6,957
-390
-5% -$26.2K
ACN icon
124
Accenture
ACN
$106B
$440K 0.01%
1,426
– –
NVS icon
125
Novartis
NVS
$302B
$424K 0.01%
4,200
– –
3 4
5
6 7

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q2 2023 Portfolio in Review

As of Q2 2023, Beck Mack & Oliver held 177 positions worth $3.83B, up 11% from $3.46B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4%. Beck Mack & Oliver opened 6 new positions and exited 1, leaving the 177-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 39% a quarter earlier, followed by Technology and Healthcare.

  • Beck Mack & Oliver's largest Q2 2023 buy was Rush Enterprises Class A: 545,486 shares worth $22.1M.
  • Beck Mack & Oliver added most to Labcorp in Q2 2023, an estimated $18.1M increase.
  • Beck Mack & Oliver's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $15.9M.
  • Beck Mack & Oliver fully exited CAE Inc. Common Shares in Q2 2023, selling an estimated $224K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $3.83B portfolio in Q2 2023.
  • Beck Mack & Oliver opened 6 new positions and closed 1 in Q2 2023.
  • Beck Mack & Oliver's portfolio value rose 11% quarter-over-quarter to $3.83B.

Based on Beck Mack & Oliver's 13F filing for Q2 2023, filed 8 Aug 2023.